Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTITUMOR ACTIVITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2824 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kim, KD; Choi, SC; Kim, A; Choe, YK; Choe, IS; Lim, JS
      Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Uherek, C; Groner, B; Wels, W
      Chimeric antigen receptors for the retargeting of cytotoxic effector cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    3. Griffith, TS; Broghammer, EL
      Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

      MOLECULAR THERAPY
    4. Zisman, A; Ng, CP; Pantuck, AJ; Bonavida, B; Belldegrun, AS
      Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis

      JOURNAL OF IMMUNOTHERAPY
    5. Marten, A; Ziske, C; Schottker, B; Renoth, S; Weineck, S; Buttgereit, P; Schakowski, F; von Rucker, A; Sauerbruch, T; Schmidt-Wolf, IGH
      Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations

      JOURNAL OF IMMUNOTHERAPY
    6. Zellweger, T; Miyake, H; July, LV; Akbari, M; Kiyama, S; Gleave, ME
      Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin

      NEOPLASIA
    7. Charmantray, F; Duflos, A; Lhomme, J; Demeunynck, M
      Synthesis and study of 4-hydroxymethyl-3-(alkylamino) acridines as models of a new class of DNA-intercalating-alkylating agents

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    8. Mehrabani, F; Pindur, U
      Synthesis of new bis(tetrahydropyrrolo[3,4-b]carbazoles) with a functionalized diaryl spacer

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    9. Pettinari, C; Marchetti, F; Pettinari, R; Martini, D; Drozdov, A; Troyanov, S
      The interaction of organotin(IV) acceptors with a benzoic acid containing two pyrazolone groups

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    10. Gunzburg, WH; Salmons, B
      Novel clinical strategies for the treatment of pancreatic carcinoma

      TRENDS IN MOLECULAR MEDICINE
    11. Brinkmann, U; Keppler-Hafkemeyer, A; Hafkemeyer, P
      Recombinant immunotoxins for cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    12. Sinha, SC; Sun, J; Wartmann, M; Lerner, RA
      Synthesis of epothilone analogues by antibody-catalyzed resolution of thiazole aldol synthons on a multigram scale. Biological consequences of C-13 alkylation of epothilones

      CHEMBIOCHEM
    13. Pettinari, C; Marchetti, F; Cingolani, A; Gindulyte, A; Massa, L; Rossi, M; Caruso, F
      syn-anti Conversion in octahedral bis(beta-diketonato)diorganotin(IV) derivatives containing fluorinated 4-acyl-5-pyrazolonato donors

      EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
    14. Hawkes, GE; O'Brien, P; Salacinski, H; Motevalli, M; Abrahams, I
      Solid and solution state NMR spectra and the structure of the gallium citrate complex (NH4)(3)[Ga(C6H5O7)(2)]center dot 4H(2)O

      EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
    15. Haufe, G; Burchardt, A
      Synthesis of a fluorinated ether lipid analogous to a platelet activating factor

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    16. Schmidt, F; Ungureanu, I; Duval, R; Pompon, A; Monneret, C
      Cancer chemotherapy: A paclitaxel prodrug for ADEPT (antibody-directed enzyme prodrug therapy)

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    17. Golos, B; Dzik, JM; Kazimierczuk, Z; Ciesla, J; Zielinski, Z; Jankowska, J; Kraszewski, A; Stawinski, J; Rode, W; Shugar, D
      Interaction of thymidylate synthase with the 5 '-thiophosphates, 5 '-dithiophosphates, 5 '-H-phosphonates and 5 '-S-thiosulfates of 2 '-deoxyuridine,thymidine and 5-fluoro-2 '-deoxyuridine

      BIOLOGICAL CHEMISTRY
    18. Tamanoi, F; Gau, CL; Jiang, C; Edamatsu, H; Kato-Stankiewicz, J
      Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells

      CELLULAR AND MOLECULAR LIFE SCIENCES
    19. Zuo, DS; Jiang, T; Guan, HS; Wang, KQ; Qi, X; Shi, Z
      Synthesis, structure and antitumor activity of dibutyltin oxide complexes with 5-fluorouracil derivatives. Crystal structure of [(5-fluorouracil)-1-CH2CH2COOSn(n-Bu)(2)](4)O-2

      MOLECULES
    20. Wang, XH; Liu, JT; Li, JX; Liu, JF
      Synthesis, characterization and in vitro antitumor activity of diorganometallo complexes gamma-Keggin anions

      INORGANIC CHEMISTRY COMMUNICATIONS
    21. Gokhale, N; Padhye, S; Rathbone, D; Billington, D; Lowe, P; Schwalbe, C; Newton, C
      The crystal structure of first copper(II) complex of a pyridine-2-carboxamidrazone - a potential antitumor agent

      INORGANIC CHEMISTRY COMMUNICATIONS
    22. Palumbo, M; Sissi, C; Gatto, B; Moro, S; Zagotto, G
      Quantitation of camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    23. Zufia, L; Aldaz, A; Giraldez, J
      Separation methods for camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    24. Van Kuilenburg, ABP; Stroomer, AEM; Peters, GJ; Van Gennip, AH
      Simultaneous determination of F-beta-alanine and beta-alanine in plasma and urine with dual-column reversed-phase high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    25. Menoli, RCRN; Mantovani, MS; Ribeiro, LR; Speit, G; Jordao, BQ
      Antimutagenic effects of the mushroom Agaricus blazei Murrill extracts on V79 cells

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    26. Delmanto, RD; de Lima, PLA; Sugui, MM; da Eira, AF; Salvadori, DMF; Speit, G; Ribeiro, LR
      Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    27. Chung, WY; Jung, YJ; Surh, YJ; Lee, SS; Park, KK
      Antioxidative and antitumor promoting effects of [6]-paradol and its homologs

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    28. Fahy, J
      Modifications in the "upper" or velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities

      CURRENT PHARMACEUTICAL DESIGN
    29. Hill, BT
      Vinflunine, a second generation novel Vinca alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for futuremitotic blockers

      CURRENT PHARMACEUTICAL DESIGN
    30. Bissery, MC
      Preclinical evaluation of new taxoids

      CURRENT PHARMACEUTICAL DESIGN
    31. Altmann, KH
      Microtubule-stabilizing agents: a growing class of important anticancer drugs

      CURRENT OPINION IN CHEMICAL BIOLOGY
    32. Nagane, M; Huang, HJS; Cavenee, WK
      The potential of TRAIL for cancer chemotherapy

      APOPTOSIS
    33. Martin, DS; Spriggs, D; Koutcher, JA
      A concomitant ATP-depleting strategy markedly enhances anticancer agent activity

      APOPTOSIS
    34. Nicolaou, KC; Ritzen, A; Namoto, K
      Recent developments in the chemistry, biology and medicine of the epothilones

      CHEMICAL COMMUNICATIONS
    35. Cortesi, R; Nastruzzi, C
      Delivery systems for DNA-binding drugs as gene expression modulators

      DRUG DISCOVERY TODAY
    36. Hicklin, DJ; Witte, L; Zhu, ZP; Liao, F; Wu, Y; Li, YW; Bohlen, P
      Monoclonal antibody strategies to block angiogenesis

      DRUG DISCOVERY TODAY
    37. Dutcher, J; Atkins, MB; Margolin, K; Weiss, G; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part II: Management of IL-2 toxicity and studies with other cytokines

      MEDICAL ONCOLOGY
    38. Marchini, S; Broggini, M; Sessa, C; D'Incalci, M
      Development of distamycin-related DNA binding anticancer drugs

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    39. Simpson, D
      Tresperimus: a new agent for transplant tolerance induction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    40. Caruso, F; Rossi, M; Pettinari, C
      Anticancer titanium agents

      EXPERT OPINION ON THERAPEUTIC PATENTS
    41. Dumas, J
      Protein kinase inhibitors: emerging pharmacophores 1997-2000

      EXPERT OPINION ON THERAPEUTIC PATENTS
    42. Lui, VWY; Falo, LD; Huang, L
      Systemic production of IL-12 by naked DNA mediated gene transfer: toxicityand attenuation of transgene expression in vivo

      JOURNAL OF GENE MEDICINE
    43. Beutler, E; Gelbart, T; West, C
      Synergy between TLR2 and TLR4: A safety mechanism

      BLOOD CELLS MOLECULES AND DISEASES
    44. Synold, TW; Dussault, I; Forman, BM
      The orphan nuclear receptor SXR coordinately regulates drug metabolism andefflux

      NATURE MEDICINE
    45. Lawrence, D; Shahrokh, Z; Marsters, S; Achilles, K; Shih, D; Mounho, B; Hillan, K; Totpal, K; DeForge, L; Schow, P; Hooley, J; Sherwood, S; Pai, R; Leung, S; Khan, LL; Gliniak, B; Bussiere, J; Smith, CA; Strom, SS; Kelley, S; Fox, JA; Thomas, D; Ashkenazi, A
      Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

      NATURE MEDICINE
    46. Nicoletti, MI; Valoti, G; Giannakakou, P; Zhan, ZR; Kim, JH; Lucchini, V; Landoni, F; Mayo, JG; Giavazzi, R; Fojo, T
      Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-anticancer drug screen: Correlation with sensitivity to microtubule active agents

      CLINICAL CANCER RESEARCH
    47. Sausville, EA
      Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: Sequenceand tumor biology matters - Commentary re: P. Munster et al., modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. Clin. Cancer Res., 7: 2228-2236, 2001.

      CLINICAL CANCER RESEARCH
    48. Tortora, G; Caputo, R; Damiano, V; Bianco, R; Fontanini, G; Cuccato, S; De Placido, S; Bianco, AR; Ciardiello, F
      Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis

      CLINICAL CANCER RESEARCH
    49. Rudin, CM; Holmlund, J; Fleming, GF; Mani, S; Stadler, WM; Schumm, P; Monia, BP; Johnston, JF; Geary, R; Yu, RZ; Kwoh, TJ; Dorr, FA; Ratain, MJ
      Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer

      CLINICAL CANCER RESEARCH
    50. Ciardiello, F; Caputo, R; Bianco, R; Damiano, V; Fentanini, G; Cuccato, S; De Placido, S; Bianco, AR; Tortora, G
      Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor

      CLINICAL CANCER RESEARCH
    51. Butler, LM; Webb, Y; Agus, DB; Higgins, B; Tolentino, TR; Kutko, MC; LaQuaglia, MP; Drobnjak, M; Cordon-Cardo, C; Scher, HI; Breslow, R; Richon, VM; Rifkind, RA; Marks, PA
      Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase

      CLINICAL CANCER RESEARCH
    52. Williams, JI; Weitman, S; Gonzalez, CM; Jundt, CH; Marty, J; Stringer, SD; Holroyd, KJ; McLane, MP; Chen, QM; Zasloff, M; Von Hof, DD
      Squalamine treatment of human tumors in nu/nu mice enhances platinum-basedchemotherapies

      CLINICAL CANCER RESEARCH
    53. Ryan, DP; Supko, JG; Eder, JP; Seiden, MV; Demetri, G; Lynch, TJ; Fischman, AJ; Davis, J; Jimeno, J; Clark, JW
      Phase I and pharmacokinetic study of esteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies

      CLINICAL CANCER RESEARCH
    54. Harvey, S; Decker, R; Dal, Y; Schaefer, G; Tang, L; Kramer, L; Dent, P; Grant, S
      Interactions between 2-fluoroadenine 9-beta-d-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells

      CLINICAL CANCER RESEARCH
    55. Ciardiello, F; Tortora, G
      A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptor

      CLINICAL CANCER RESEARCH
    56. Lyass, O; Hubert, A; Gabizon, AA
      Phase I study of doxil-cisplatin combination chemotherapy in patients withadvanced malignancies

      CLINICAL CANCER RESEARCH
    57. Minami, H; Fujii, H; Igarashi, T; Itoh, K; Tamanoi, K; Oguma, T; Sasaki, Y
      Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks

      CLINICAL CANCER RESEARCH
    58. Khokhar, NZ; She, Y; Rusch, VW; Sirotnak, FM
      Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: Further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums

      CLINICAL CANCER RESEARCH
    59. Takahashi, N; Li, WW; Banerjee, D; Scotto, KW; Bertino, JR
      Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells

      CLINICAL CANCER RESEARCH
    60. Blaney, S; Berg, SL; Pratt, C; Weitman, S; Sullivan, J; Luchtman-Jones, L; Bernstein, M
      A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study

      CLINICAL CANCER RESEARCH
    61. Li, ML; Horn, L; Firby, PS; Moore, MJ
      Pharmacological determinants of 9-aminocamptothecin cytotoxicity

      CLINICAL CANCER RESEARCH
    62. Takebayashi, Y; Goldwasser, F; Urasaki, Y; Kohlhagen, G; Pommier, Y
      Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression

      CLINICAL CANCER RESEARCH
    63. Bayer, T; Riemer, C; Kessler, H
      A new strategy for the synthesis of cyclopeptides containing diaminoglutaric acid

      JOURNAL OF PEPTIDE SCIENCE
    64. Sotnichenko, AI; Zabolotnev, DV; Severin, SE; Shvets, VI
      A new efficient technology for the isolation of human alpha-fetoprotein and the status of free sulfhydryl and amino groups in the resulting preparation

      RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
    65. Kabbaj, M; Phillips, NC
      Anticancer activity of mycobacterial DNA: Effect of formulation as chitosan nanoparticles

      JOURNAL OF DRUG TARGETING
    66. Kuhn, JG
      Fluorouracil and the new oral fluorinated pyrimidines

      ANNALS OF PHARMACOTHERAPY
    67. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    68. Conte, PF; Gadducci, A; Cianci, C
      Second-line treatment and consolidation therapies in advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    69. Antunes, LMG; Darin, JDAC; Bianchi, MDP
      Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats

      PHARMACOLOGICAL RESEARCH
    70. Kramer, OH; Gottlicher, M; Heinzel, T
      Histone deacetylase as a therapeutic target

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    71. Searle, F; Gac-Breton, S; Keane, R; Dimitrijevic, S; Brocchini, S; Sausville, EA; Duncan, R
      N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation

      BIOCONJUGATE CHEMISTRY
    72. Decker, T; Peschel, C
      Effect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells

      LEUKEMIA & LYMPHOMA
    73. Karp, JE; Kaufmann, SH; Adjei, AA; Lancet, JE; Wright, JJ; End, DW
      Current status of clinical trials of farnesyltransferase inhibitors

      CURRENT OPINION IN ONCOLOGY
    74. Kruczynski, A; Hill, BT
      Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    75. Hayes, RL; Arbit, E; Odaimi, M; Pannullo, S; Scheff, R; Kravchinskiy, D; Zaroulis, C
      Adoptive cellular immunotherapy for the treatment of malignant gliomas

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    76. Ranson, MR; Cheeseman, S; White, S; Margison, J
      Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breastcancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    77. Giavazzi, R; Taraboletti, G
      Preclinical development of metalloproteasis inhibitors in cancer therapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    78. Nelkin, BD; Ball, DW
      Combretastatin A-4 and doxorubicin combination treatment is effective in apreclinical model of human medullary thyroid carcinoma

      ONCOLOGY REPORTS
    79. Okamoto, R; Takano, H; Sekikawa, T; Tanaka, T; Toyada, M; Ukon, K; Tanimoto, K; Kumazaki, T; Nishiyama, M
      Unique action determinants of double acting topoisomerase inhibitor, TAS-103

      INTERNATIONAL JOURNAL OF ONCOLOGY
    80. Smid, K; Van Moorsel, CJA; Noordhuis, P; Voorn, DA; Peters, GJ
      Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay

      INTERNATIONAL JOURNAL OF ONCOLOGY
    81. Redkar, AA; Meadows, GG; Daoud, SS
      UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice

      INTERNATIONAL JOURNAL OF ONCOLOGY
    82. Zou, YY; Wu, QP; Tansey, W; Chow, D; Hung, MC; Vej, CC; Wallace, S; Li, C
      Effectiveness of water soluble poly(L-glutamic acid)camptothecin conjugateagainst resistant human lung cancer xenografted in nude mice

      INTERNATIONAL JOURNAL OF ONCOLOGY
    83. Wang, LS; Zhu, HM; Zhou, DY; Wang, YL; Zhang, WD
      Influence of whole peptidoglycan of bifidobacterium on cytotoxic effectorsproduced by mouse peritoneal macrophages

      WORLD JOURNAL OF GASTROENTEROLOGY
    84. Lu, Y; Yamauchi, N; Koshita, Y; Fujiwara, H; Sato, Y; Fujii, S; Takahashi, M; Sato, T; Kato, J; Yamagishi, H; Niitsu, Y
      Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule

      GENE THERAPY
    85. Chen, Y; Lenert, P; Weeratna, R; McCluskie, M; Wu, T; Davis, HL; Krieg, AM
      Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs

      GENE THERAPY
    86. Miller, CT; Weragoda, R; Izbicka, E; Iverson, BL
      The synthesis and screening of 1,4,5,8-naphthalenetetracarboxylic diimide-peptide conjugates with antibacterial activity

      BIOORGANIC & MEDICINAL CHEMISTRY
    87. Melliou, E; Magiatis, P; Mitaku, S; Skaltsounis, AL; Pierre, A; Atassi, G; Renard, P
      2,2-Dimethyl-2H-anthra[2,3-b]pyran-6,11-diones: A new class of cytotoxic compounds

      BIOORGANIC & MEDICINAL CHEMISTRY
    88. Mekapati, SB; Denny, WA; Kurup, A; Hansch, C
      QSAR of anticancer compounds. Bis(11-oxo-11H-indeno[1,2-b]quinoline-6-carboxamides), bis(phenazine-1-carboxamides), and bis(naphthalimides)

      BIOORGANIC & MEDICINAL CHEMISTRY
    89. Kostakis, IK; Pouli, N; Marakos, P; Mikros, E; Skaltsounis, AL; Leonce, S; Atassi, G; Renard, P
      Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-ones

      BIOORGANIC & MEDICINAL CHEMISTRY
    90. Chordia, MD; Yuan, HQ; Jagtap, PG; Kadow, JF; Long, BH; Fairchild, CR; Johnston, KA; Kingston, DGI
      Synthesis and bioactivity of 2,4-diacyl analogues of paclitaxel

      BIOORGANIC & MEDICINAL CHEMISTRY
    91. Schmid, P; Possinger, K
      Liposomal anthracyclines for improved cardiac tolerability

      BREAST
    92. Gwaltney, SL; Imade, HM; Barr, KJ; Li, Q; Gehrke, L; Credo, RB; Warner, RB; Lee, JY; Kovar, P; Wang, JY; Nukkala, MA; Zielinski, NA; Frost, D; Ng, SC; Sham, HL
      Novel sulfonate analogues of combretastatin A-4: Potent antimitotic agents

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    93. Dallavalle, S; Ferrari, A; Merlini, L; Penco, S; Carenini, N; De Cesare, M; Perego, P; Pratesi, G; Zunino, F
      Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    94. Iimura, S; Uoto, K; Ohsuki, S; Chiba, J; Yoshino, T; Iwahana, M; Jimbo, T; Terasawa, H; Soga, T
      Orally active docetaxel analogue: Synthesis of 10-deoxy-10-C-morpholinoethyl docetaxel analogues

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    95. Ingallinella, P; Di Marco, A; Taliani, M; Fattori, D; Pessi, A
      A new method for chemoselective conjugation of unprotected peptides to dauno- and doxorubicin

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    96. Franchetti, P; Marchetti, S; Cappellacci, L; Yalowitz, JA; Jayaram, HN; Goldstein, BM; Grifantini, M
      A new C-nucleoside analogue of tiazofurin: Synthesis and biological evaluation of 2-beta-D-ribofuranosylimidazole-4-carboxamide (imidazofurin)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    97. Cavaletti, G; Tredici, G; Petruccioli, MG; Donde, E; Tredici, P; Marmiroli, P; Minoia, C; Ronchi, A; Bayssas, M; Etienne, GG
      Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat

      EUROPEAN JOURNAL OF CANCER
    98. Harrington, KJ; Lewanski, C; Northcote, AD; Whittaker, J; Peters, AM; Vile, RG; Stewart, JSW
      Phase II study of pegylated liposomal doxorubicin (Caelyx (TM)) as induction chemotherapy for patients with squamous cell cancer of the head and neck

      EUROPEAN JOURNAL OF CANCER
    99. Fukushima, M; Fujioka, A; Uchida, J; Nakagawa, F; Takechi, T
      Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo

      EUROPEAN JOURNAL OF CANCER
    100. Erba, E; Bergamaschi, D; Bassano, L; Damia, G; Ronzoni, S; Faircloth, GT; D'Incalci, M
      Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action

      EUROPEAN JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 04:10:24